Ao L相关文献与解析，生知库 | 链接生命科学的每一步

[Very low-level viremia: new clinical attention-requiring problem during the course of anti-hepatitis B virus treatment]

【极低水平病毒血症：抗乙型肝炎病毒治疗过程中需要关注的新临床问题】

期刊:Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

影响因子:

doi:10.3760/cma.j.cn501113-20210830-00442

Shi, Y J; Ding, Y; Ao, L; Zhang, D Z; Cai, D C

Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells

表观基因组学改变和动态转录变化在5-氟尿嘧啶刺激反应中揭示了结直肠癌细胞获得性耐药的机制。

期刊:Pharmacogenomics Journal

影响因子:2.9

doi:10.1038/tpj.2016.91

Shen, Y; Tong, M; Liang, Q; Guo, Y; Sun, H Q; Zheng, W; Ao, L; Guo, Z; She, F

Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy

基于5-氟尿嘧啶化疗的个体化预后特征区分的结直肠癌亚型的多组学图谱

期刊:Oncogenesis

影响因子:6.4

doi:10.1038/oncsis.2016.51

Tong, M; Zheng, W; Li, H; Li, X; Ao, L; Shen, Y; Liang, Q; Li, J; Hong, G; Yan, H; Cai, H; Li, M; Guan, Q; Guo, Z

SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.

SOX30 是一种新型的表观遗传沉默肿瘤抑制因子，它通过转录激活 p53 来促进肺癌中的肿瘤细胞凋亡

期刊:Oncogene

影响因子:7.3

doi:10.1038/onc.2014.370

Han F, Liu W, Jiang X, Shi X, Yin L, Ao L, Cui Z, Li Y, Huang C, Cao J, Liu J

[Study on F9 gene expression downregulation and its clinical value in hepatocellular carcinoma]

【F9基因表达下调及其在肝细胞癌中的临床价值研究】

[Very low-level viremia: new clinical attention-requiring problem during the course of anti-hepatitis B virus treatment]

【极低水平病毒血症：抗乙型肝炎病毒治疗过程中需要关注的新临床问题】

Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells

表观基因组学改变和动态转录变化在5-氟尿嘧啶刺激反应中揭示了结直肠癌细胞获得性耐药的机制。

Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy

基于5-氟尿嘧啶化疗的个体化预后特征区分的结直肠癌亚型的多组学图谱

SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.

SOX30 是一种新型的表观遗传沉默肿瘤抑制因子，它通过转录激活 p53 来促进肺癌中的肿瘤细胞凋亡